A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease.

Trial Profile

A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Taliglucerase alfa (Primary)
  • Indications Gaucher's disease
  • Focus Therapeutic Use
  • Sponsors Protalix Biotherapeutics
  • Most Recent Events

    • 11 Dec 2015 Protocol has been amended from change in time frame of primary endpoint from 21 months to 60 months,
    • 10 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top